Table 2

Utilization of healthcare among patients with metastatic lung cancer receiving chemotherapy

Value


n = 4068

Inpatient, mean

Acute hospital

Admissions (#)

1.5

Days (#)

8.9

Outpatient Services, mean

Physician Office (#)

41.5

Emergency Room (#)

1.6

Hospital Outpatient (#)

18.2

Home Health (#)

4.7

Other (#)

10.1

Pharmacy Prescriptions (#), mean

39.7

Inpatient, n (%)

Acute hospital

2,933

(72.1%)

Outpatient Services*, n (%)

Emergency Room

2,532

(62.2%)

Physician Office/Hospital Outpatient

Evaluation and Management

3,947

(97.0%)

Laboratory

3,331

(81.9%)

Radiology Diagnostic

3,691

(90.7%)

Radiology Therapeutic

2,241

(55.1%)

Nuclear Medicine

1,826

(44.9%)

Anesthesia and invasive procedures

2,581

(63.4%)

Blood & Transfusion

338

(8.3%)

Physical & Occupational Therapy

402

(9.9%)

Medical & Surgical Supplies

2,104

(51.7%)

Mental health-care

2,772

(68.1%)

Other

134

(3.3%)

Chemo administration

3,943

(96.9%)

Subtotal

4,032

(99.1%)

Home Health/Hospice/Skilled Nursing

2,200

(54.1%)

Other

3,314

(81.5%)

Total

4,053

(99.6%)

Medication, n (%)

Chemotherapy

4,068

(100.0%)

G-CSF

1,159

(28.5%)

ESAs

1,859

(45.7%)

Pain, sedatives, antidepressants

3,629

(89.2%)

Anti-infectives

2,991

(73.5%)

Anti-emetics

3,445

(84.7%)

Bisphosphonates

721

(17.7%)

Biologics

186

(4.6%)

Gastrointestinal

2,337

(57.4%)

Electrolytes, Caloric, Water

1,981

(48.7%)

Cardiovascular

2,161

(53.1%)

Blood products & Anticoagulants

1,393

(34.2%)

Other

3,976

(97.7%)

Total

4,068

(100.0%)

TOTAL

4,068

(100.0%)


*Other than medication administration

Vera-Llonch et al. BMC Health Services Research 2011 11:305   doi:10.1186/1472-6963-11-305

Open Data